Related Experiment Video
Updated: Jun 22, 2026

07:30
Creating Radio-cephalic Arteriovenous Fistula in the Forearm with a Modified No-Touch Technique
Published on: April 1, 2022
[Midarm arteriovenous fistula: single-center experience]
M Borzumati1, P Vio, F Bonvegna
1Struttura Complessa Nefrologia e Dialisi, Verbania, Italy. maurizio.borzumati@tiscali.it
Summary
Midarm arteriovenous fistulas (AVFs) offer excellent survival in uremic patients with diabetes or vascular disease, outperforming wrist AVFs. This proximal approach is a viable alternative for challenging hemodialysis access.
Area of Science:
- Nephrology
- Vascular Surgery
- Vascular Access
Context:
- Radiocephalic arteriovenous fistulas (AVFs) on the wrist are standard for hemodialysis but have limited survival in older patients with diabetes or severe vascular disease.
- The growing prevalence of these comorbidities necessitates alternative vascular access strategies.
- Distal AVFs frequently fail in this patient population, leading to a need for secondary or alternative access methods.
Purpose:
- To evaluate the efficacy and survival of midarm arteriovenous fistulas (AVFs) created using the proximal radial artery.
- To assess the midarm AVF as a primary or secondary vascular access option in patients with challenging vascular conditions.
- To compare the outcomes of midarm AVFs with traditional distal AVFs in specific patient cohorts.
Summary:
- Nineteen midarm AVFs were created using the proximal radial artery between 2006-2007.
- Midarm AVFs served as a secondary choice in 70% of cases and primary in 30%.
- Excellent survival was observed, with only one thrombosis and 14 functioning accesses after 6 months; four cases were lost due to patient death.
Impact:
- Midarm AVFs demonstrate excellent patency and survival, particularly in patients with diabetes and generalized vascular disease.
- This technique offers a valuable alternative to distal AVFs, potentially becoming the preferred choice for specific high-risk patient groups.
- The study suggests midarm AVFs are a crucial option, not just as an intermediate step but as a primary solution for challenging hemodialysis access needs.
Related Concept Videos
Hemodialysis I: Introduction
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
Hemodialysis II: Procedure and Complications
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...

